Related Experiment Video
Updated: Aug 6, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state
Jason H Kurzer1, Pipsa Saharinen, Olli Silvennoinen
1Department of Molecular and Integrative Physiology, The University of Michigan Medical School, Ann Arbor, MI 48109-0622, USA.
Abstract:
The tyrosine kinase Janus kinase 2 (JAK2) transduces signaling for the majority of known cytokine receptor family members and is constitutively activated in some cancers. Here we examine the mechanisms by which the adapter proteins SH2-Bbeta and APS regulate the activity of JAK2. We show that like SH2-Bbeta, APS binds JAK2 at multiple sites and that binding to phosphotyrosine 813 is essential for APS to increase active JAK2 and to be phosphorylated by JAK2. Binding of APS to a phosphotyrosine 813-independent site inhibits JAK2. Both APS and SH2-Bbeta increase JAK2 activity independent of their N-terminal dimerization domains. SH2-Bbeta-induced increases in JAK2 dimerization require only the SH2 domain and only one SH2-Bbeta to be bound to a JAK2 dimer. JAK2 mutations and truncations revealed that amino acids 809 to 811 in JAK2 are a critical component of a larger regulatory region within JAK2, most likely including amino acids within the JAK homology 1 (JH1) and JH2 domains and possibly the FERM domain. Together, our data suggest that SH2-Bbeta and APS do not activate JAK2 as a consequence of their own dimerization, recruitment of an activator of JAK2, or direct competition with a JAK2 inhibitor for binding to JAK2. Rather, they most likely induce or stabilize an active conformation of JAK2.
Insights
Adapter proteins SH2-Bbeta and APS regulate Janus kinase 2 (JAK2) activity. They likely stabilize an active JAK2 conformation, rather than recruiting activators or inhibiting competitors.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Janus kinase 2 (JAK2) is a tyrosine kinase crucial for cytokine receptor signaling.
- Constitutive JAK2 activation is implicated in certain cancers.
- Adapter proteins SH2-Bbeta and APS are investigated for their roles in JAK2 regulation.
Purpose of the Study:
- To elucidate the mechanisms by which SH2-Bbeta and APS modulate JAK2 activity.
- To identify specific binding sites and their functional consequences on JAK2.
- To understand the structural elements of JAK2 critical for its regulation.
Main Methods:
- Analysis of JAK2 binding sites for SH2-Bbeta and APS.
- Phosphorylation assays to assess JAK2 activity.
- Site-directed mutagenesis and truncation studies of JAK2.
- Investigation of the role of SH2-Bbeta dimerization domains.
Main Results:
- APS binds JAK2 at multiple sites; binding to phosphotyrosine 813 enhances JAK2 activity, while other sites inhibit it.
- Both SH2-Bbeta and APS increase JAK2 activity independently of their N-terminal dimerization domains.
- SH2-Bbeta-mediated JAK2 dimerization requires its SH2 domain and binding to a JAK2 dimer.
- JAK2 amino acids 809-811 are part of a critical regulatory region.
Conclusions:
- SH2-Bbeta and APS activate JAK2 by inducing or stabilizing an active conformation.
- Activation is not mediated by adapter protein dimerization, recruitment of activators, or displacement of inhibitors.
- Specific binding interactions and structural elements within JAK2 are key to its regulation by these adapter proteins.
Related Concept Videos
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Cooperative Binding of Transcription Regulators
Cooperative Binding of Transcription Regulators
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Co-activators and Co-repressors

